Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Aloia, Ashok Vaswani, James Yeh, K. Ellis, Seiichi Yasumura, S. Cohn (1988)
Calcitriol in the treatment of postmenopausal osteoporosis.The American journal of medicine, 84 3 Pt 1
H. Reichel, H. Koeffler, A. Norman (1989)
The role of the vitamin D endocrine system in health and disease.The New England journal of medicine, 320 15
Stella Milsom, Kaye Ibbertson, Sharon Hannan, David Shaw, John Pybus (1987)
Simple test of intestinal calcium absorption measured by stable strontium.British Medical Journal (Clinical research ed.), 295
B. Riggs, L. Melton (1983)
Evidence for two distinct syndromes of involutional osteoporosis.The American journal of medicine, 75 6
R. Heaney (1995)
Interpreting trials of bone-active agents.The American journal of medicine, 98 4
P. Ebeling, M Sandgren, E DiMagno, A Lane, H. DeLuca, B. Riggs (1992)
Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women.The Journal of clinical endocrinology and metabolism, 75 1
S. Cummings, W. Browner, D. Bauer, K. Stone, K. Ensrud, S. Jamal, B. Ettinger (1998)
Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group.The New England journal of medicine, 339 11
S. Ott, C. Chesnut (1989)
Calcitriol treatment is not effective in postmenopausal osteoporosis.Annals of internal medicine, 110 4
J. Gallagher, D. Goldgar (1990)
Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.Annals of internal medicine, 113 9
R. Francis, M. Peacock (1987)
Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis.The American journal of clinical nutrition, 46 2
J. MacLaughlin, M. Holick (1985)
Aging decreases the capacity of human skin to produce vitamin D3.The Journal of clinical investigation, 76 4
J. Quesada, A. Mateo, I. Jans, Mariano Rodríguez, R. Bouillon (1994)
Calcitriol corrects deficient calcitonin secretion in the vitamin D‐deficient elderlyJournal of Bone and Mineral Research, 9
K. Tsai, H. Heath, R. Kumar, B. Riggs (1984)
Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis.The Journal of clinical investigation, 73 6
M. Tilyard, G. Spears, Janet Thomson, S. Dovey (1992)
Treatment of postmenopausal osteoporosis with calcitriol or calcium.The New England journal of medicine, 326 6
Marius Ooms, J. Roos, P. Bezemer, W. Vijgh, L. Bouter, P. Lips (1995)
Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial.The Journal of clinical endocrinology and metabolism, 80 4
R. Bouillon, J. Auwerx, W. Lissens, W. Pelemans (1987)
Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency.The American journal of clinical nutrition, 45 4
G. Ledger, M. Burritt, P Kao, W. O'Fallon, B. Riggs, S. Khosla (1995)
Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption.The Journal of clinical endocrinology and metabolism, 80 11
D. Prockop, S. Udenfriend (1960)
A specific method for the analysis of hydroxyproline in tissues and urine.Analytical biochemistry, 1
To evaluate the long-term effect of calcitriol treatment on bone mineral density (BMD) of the femoral neck and lumbar spine and the parameters of calcium and bone metabolism in elderly women, 55 healthy, postmenopausal women, all aged 66 years, were enrolled in the study. Eighteen started a 4-year supplementation with 0.5 μg of calcitriol daily and 37 served as controls. Calcium intake of all the subjects was adjusted to 800 mg daily. In 4 years femoral neck BMD increased by 3.0% in the calcitriol group, but decreased by 1.6% in the control group (P= 0.009). The respective changes in lumbar spine BMD were +2.3% and +0.9% (P= 0.067). Two years' treatment with calcitriol increased the intestinal absorption of strontium by 57% (P < 0.001), doubled the urinary excretion of calcium (P < 0.001), and decreased the mean parathyroid hormone (PTH) level by 32% (P < 0.01). In the calcitriol group the marker of bone formation, serum osteocalcin, decreased by 27% (P < 0.01), and the marker of bone resorption, serum C-telopeptide of type I collagen (CTx), by 33% (P= 0.05) after 2 years. In two subjects the calcitriol dose had to be reduced because of hypercalciuria. We conclude that calcitriol treatment increases bone mass at the femoral neck and lumbar spine, the increases being maintained for up to 4 years. The gain in bone mass results from reduced bone turnover which is partly a consequence of the enhanced intestinal absorption of calcium and suppressed serum PTH levels.
Calcified Tissue International – Springer Journals
Published: Mar 18, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.